<VariationArchive VariationID="1069385" VariationName="NM_198129.4(LAMA3):c.5546del (p.Gly1849fs)" VariationType="Deletion" Accession="VCV001069385" Version="7" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-20" DateCreated="2021-05-10" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1064502" VariationID="1069385">
      <GeneList>
        <Gene Symbol="LAMA3" FullName="laminin subunit alpha 3" GeneID="3909" HGNC_ID="HGNC:6483" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>18q11.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="18" Accession="NC_000018.10" start="23689453" stop="23955066" display_start="23689453" display_stop="23955066" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="18" Accession="NC_000018.9" start="21269561" stop="21535029" display_start="21269561" display_stop="21535029" Strand="+" />
          </Location>
          <OMIM>600805</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_198129.4(LAMA3):c.5546del (p.Gly1849fs)</Name>
      <CanonicalSPDI>NC_000018.10:23894988:GGG:GG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>18q11.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="18" Accession="NC_000018.10" start="23894989" stop="23894989" display_start="23894989" display_stop="23894989" variantLength="1" positionVCF="23894988" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="18" Accession="NC_000018.9" start="21474953" stop="21474953" display_start="21474953" display_stop="21474953" variantLength="1" positionVCF="21474952" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>G1849fs</ProteinChange>
      <ProteinChange>G240fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000018.10" sequenceAccession="NC_000018" sequenceVersion="10" change="g.23894991del" Assembly="GRCh38">
            <Expression>NC_000018.10:g.23894991del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000018.9" sequenceAccession="NC_000018" sequenceVersion="9" change="g.21474955del" Assembly="GRCh37">
            <Expression>NC_000018.9:g.21474955del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007853.2" sequenceAccession="NG_007853" sequenceVersion="2" change="g.210394del">
            <Expression>NG_007853.2:g.210394del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000227.6" sequenceAccession="NM_000227" sequenceVersion="6" change="c.719del" MANEPlusClinical="true">
            <Expression>NM_000227.6:c.719del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000218.3" sequenceAccession="NP_000218" sequenceVersion="3" change="p.Gly240fs">
            <Expression>NP_000218.3:p.Gly240fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127717.4" sequenceAccession="NM_001127717" sequenceVersion="4" change="c.5546del">
            <Expression>NM_001127717.4:c.5546del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001121189.2" sequenceAccession="NP_001121189" sequenceVersion="2" change="p.Gly1849fs">
            <Expression>NP_001121189.2:p.Gly1849fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127718.4" sequenceAccession="NM_001127718" sequenceVersion="4" change="c.719del">
            <Expression>NM_001127718.4:c.719del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001121190.2" sequenceAccession="NP_001121190" sequenceVersion="2" change="p.Gly240fs">
            <Expression>NP_001121190.2:p.Gly240fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_198129.4" sequenceAccession="NM_198129" sequenceVersion="4" change="c.5546del" MANESelect="true">
            <Expression>NM_198129.4:c.5546del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_937762.2" sequenceAccession="NP_937762" sequenceVersion="2" change="p.Gly1849fs">
            <Expression>NP_937762.2:p.Gly1849fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="760487161" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_198129.4(LAMA3):c.5546del (p.Gly1849fs) AND not provided" Accession="RCV001381237" Version="6">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_198129.4(LAMA3):c.5546del (p.Gly1849fs) AND Junctional epidermolysis bullosa" Accession="RCV002242801" Version="1">
        <ClassifiedConditionList TraitSetID="13197">
          <ClassifiedCondition DB="MedGen" ID="C0079301">Junctional epidermolysis bullosa</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-04-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-25" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2021-05-10" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10366601</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11810295</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12915477</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16473856</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17362460</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22434185</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23869449</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27827380</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28087116</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="13197" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9513" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Junctional epidermolysis bullosa</ElementValue>
                <XRef ID="MONDO:0017612" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Junctional epidermolysis bullosa (JEB) is characterized by fragility of the skin and mucous membranes, manifest by blistering with little or no trauma. Blistering may be severe and granulation tissue can form on the skin around the oral and nasal cavities, fingers and toes, and internally around the upper airway. Blisters generally heal with no significant scarring. Broad classification of JEB includes JEB generalized severe and JEB generalized intermediate. In JEB generalized severe, blisters are present at birth or become apparent in the neonatal period. Congenital malformations of the urinary tract and bladder may also occur. In JEB generalized intermediate, the phenotype may be mild with blistering localized to hands, feet, knees, and elbows with or without renal or ureteral involvement. Some individuals never blister after the newborn period. Additional features shared by JEB and the other major forms of epidermolysis bullosa (EB) include congenital localized absence of skin (aplasia cutis congenita), milia, nail dystrophy, scarring alopecia, hypotrichosis, pseudosyndactyly, and other contractures.</Attribute>
                <XRef ID="NBK1125" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2152" />
                <XRef ID="2152" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301304</ID>
                <ID Source="BookShelf">NBK1125</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Skin Cancer">
                <ID Source="PubMed">26389333</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="305" DB="Orphanet" />
              <XRef ID="C0079301" DB="MedGen" />
              <XRef ID="MONDO:0017612" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS226650" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4908033" SubmissionDate="2022-05-12" DateLastUpdated="2022-05-16" DateCreated="2022-05-16">
        <ClinVarSubmissionID localKey="NM_000227.4:c.719delG|MedGen:C0079301" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002511429" DateUpdated="2022-05-16" DateCreated="2022-05-16" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16473856</ID>
          </Citation>
          <Comment>Variant summary: LAMA3 c.719delG (p.Gly240AlafsX2) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 1.2e-05 in 250154 control chromosomes. c.719delG has been reported in the literature in individuals affected with Junctional Epidermolysis Bullosa (example, Varki_2006). These data indicate that the variant may be associated with disease. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LAMA3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000227.4:c.719delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0079301" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11463985</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3105158" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="4947774|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001579552" DateUpdated="2024-02-14" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10366601</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11810295</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12915477</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16473856</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17362460</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22434185</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23869449</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27827380</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28087116</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16473856</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Gly240Alafs*2) in the LAMA3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LAMA3 are known to be pathogenic (PMID: 10366601, 11810295, 12915477, 16473856, 17362460, 22434185, 23869449, 27827380, 28087116). This variant is present in population databases (rs760487161, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with Herlitz junctional epidermolysis bullosa (PMID: 16473856). ClinVar contains an entry for this variant (Variation ID: 1069385). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LAMA3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000018.9:g.21474953del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3105158" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4908033" TraitType="Disease" MappingType="XRef" MappingValue="C0079301" MappingRef="MedGen">
        <MedGen CUI="C0079301" Name="Junctional epidermolysis bullosa" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

